Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3897097014 | Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3897098016 | Trastuzumab deruxtecan only product in parenteral dose form | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Has manufactured dose form | Parenteral dose form (dose form) | true | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Is a | Trastuzumab only product in parenteral dose form | false | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Is a | Product containing only trastuzumab deruxtecan (medicinal product) | true | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Is a | Product containing trastuzumab deruxtecan in parenteral dose form (medicinal product form) | true | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Count of base of active ingredient | 1 (kwalificatiewaarde) | false | Inferred relationship | Some | ||
| Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Has active ingredient | Trastuzumab deruxtecan | true | Inferred relationship | Some | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Trastuzumab deruxtecan 100 mg powder for solution for infusion vial | Is a | True | Product containing only trastuzumab deruxtecan in parenteral dose form (medicinal product form) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR